Skip to main content
Premium Trial:

Request an Annual Quote

Genset Names Abarbanel CIO and CTO

NEW YORK, July 2 – Genset has named Robert Abarbanel chief information officer and chief technical officer, the company announced Monday.

Abarbanel previously worked at Boeing, where he served as a manager and principal scientist in mathematics and computing technology. Prior to that he served in the advanced technology group at Apple Computer and IntelliGenetics (acquired by Oxford Molecular Group), and was a principal investigator researching computing techniques applied to protein folding and search algorithms at the University of California. He started his career as a pediatrician at San Luke’s Hospital in San Francisco.

“The integration of biology and IT will be required to discover and develop novel genomics-based biopharmaceutical products,” Andre Pernet, CEO of Genset, said in a statement. “I truly believe that Dr. Abarbanel has the unique background as a trained physician with over 20 years in cutting edge statistical and technological advances to take us to the next level in this area.”

Abarbanel will be based at Genset’s Paris headquarters.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.